• The CRI Timeline

    The CRI Timeline

    Funding 70 Years of Discovery in Cancer Immunotherapy

  • For a World Immune to Cancer

    We established immunotherapy as the fourth pillar in treating cancer for one reason only – to save more lives.

    See the Video

Inventing the Next Wave in Immunotherapy

Breakthrough science has given researchers, clinicians, and patients new hope in the fight against cancer. With recent discoveries in immunotherapy treatments and an increased understanding of the immune system’s role in fighting disease, we are closer than ever before to transforming all cancers into curable diseases.

The Best Minds

Supporting and training scientists today for breakthrough discoveries in immunotherapy. We fund both open-ended laboratory research and data-driven clinical studies and turn discoveries into real-world results that save lives.

Promoting the Power of Our Immune System

CRI funds scientists from around the world to advance new avenues of discovery, new technologies, and new ways to analyze and share data about our immune system and its power to outsmart cancer — with the shared goal of making immunotherapy a lifesaving treatment for all cancers.

The IO Research Intelligence Center

As the science of cancer immunotherapy advances and the amount of data generated in clinical and laboratory studies grows exponentially, CRI is harnessing this information and putting it into the hands of our global community of research scientists to help speed the discovery and development of cancer cures.

Data on its own is not enough. We need to make sense of data within what we already know about cancer immunology. We need to marry data science, bioinformatics, and cancer immunology if we are going to take the next big leap of developing immunotherapies that are effective for all cancers.

Take Action

Researcher holding a vial and looking at it

Donate Now

Make a gift today to make an impact now. Memorial and Honor donations also welcome. Your tax-deductible gift will fuel the discovery and development of powerful immunotherapies for all cancers.

Donate Now
Two people looking at their mobile devices together

Other Ways to Support CRI

We offer many convenient ways to support our mission. Be a fundraiser. Make a planned gift. Donate a vehicle. Explore all the many ways you can join in our lifesaving work.

Other Ways to Give

Conquering Cancer Together

We cultivate lasting strategic partnerships with research institutions, cancer treatment centers, biopharmaceutical companies, and nonprofits to facilitate innovation in immuno-oncology and advance new lifesaving immunotherapies for more patients.

American Association for Cancer Research Logo
Abbvie Logo
AstraZeneca Logo
Boston Children's Hospital Logo
Bristol Myers Squibb logo
Dana Farber Cancer Institute Logo
Genentech Logo
MD Anderson Cancer Center Logo
Memorial Sloan Kettering Cancer Center Logo
SageBionetworks Logo
Merck Logo
NYU Logo
Ocra Logo
Parker Institue Logo
Regeneron Logo
Stanford University Logo
TelevisaUnivision Logo
University of Pennsylvania Logo


3-D image of a bar graph

Annual Reports

CRI’s annual reports recount our accomplishments in the previous fiscal year.

A pen lies on top of paper reports

Charity Ratings & Reporting

The Cancer Research Institute is a top-rated nonprofit organization.

patient speaks to a physician


Stay current on the latest cancer immunotherapy and CRI developments.

researchers in a lab

Media Room

Browse CRI press releases, news articles, and subject matter experts.

Immunotherapy patient summit sign

Patient Summits

Patient Summits connect cancer patients with scientific and medical experts.

Woman looks at her external monitor


View immunotherapy webinars and how CRI’s work is impacting cancer research.

Bring to Life More Cures, Together

Become part of CRI’s mission to create a
world immune to cancer

Donate Now

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.